Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the most promising stocks according to Wall Street analysts. On June 26, ...

A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

The best shower temperature for your health depends on your goals. Experts recommend showering in lukewarm water, but there ...

New data reveals sponsors risk wasting billions by designing overly complex trials and repeatedly recruiting from oversaturated investigator sites Boston, US. 9 July, 2025. Dr. Gen Li, CEO of Phesi, a ...

Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid. Click here to find out why AMGN stock is a Buy.

Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my ...

Connect Biopharma (CNTB) announced that the Company’s collaborator and exclusive licensee in China, Simcere Pharmaceutical, has submitted its New ...

A study found that walking on forest roads has a greater health promotion effect than walking in cities. Researchers at the ...

Integrated Dermatology and Shady Grove Dermatology mark two years of growth and expanded access to expert dermatology care in Rockville, Maryland.